// App-Quantinova.ai

5669 : Differential prognosis of immune biomarkers in metastatic vs. early triple negative breast cancer (TNBC) settings

Researchers

Presenter

  • Kelly J. Dupree

Principal Investigators

  • Ching-Wei Chang

  • Meghna Das Thakur

  • Timothy R. Wilson

  • David Shames

  • David Cameron

  • Luciana Molinero

Medical Centers

  • Roche/Genentech, South San Francisco, CA

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Triple-negative breast cancer

  • Breast cancer

  • Solid malignancies

Biomarkers

  • Cluster of differentiation 8A

  • C-X-C motif chemokine 10

  • C-X-C motif chemokine ligand 9

  • Interferon-gamma

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved